+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Acura Pharmaceuticals Inc
  • Avancen MOD Corporation
  • Cara Therapeutics Inc
  • CareFusion Corp
  • Cephalon Inc
  • Curlin Medical, Inc.
  • MORE
AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Key Information Included
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo in Europe), is a single sufentanil sublingual tablet for treating of moderate-to-severe acute pain. Its pipeline also includes Zalviso, a drug and device combination product for management of moderate to severe acute pain in adults. AcelRx developed a proprietary, non-invasive, sublingual formulation technology to deliver its highly lipophilic drugs. The company commercializes its EC approved Zalviso under license agreement with Grunenthal in various European Union countries and Australia. AcelRx is headquartered in Redwood City, California, the US.

AcelRx Pharmaceuticals Inc Key Recent Developments

Aug 05, 2019: AcelRx Pharmaceuticals reports second quarter 2019 financial results
May 08, 2019: AcelRx Pharmaceuticals reports first quarter 2019 financial results
Mar 07, 2019: AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
Nov 02, 2018: Acelrx Pharmaceuticals reports third quarter 2018 financial results and provides corporate update
Oct 12, 2018: AcelRx Pharmaceuticals Stock Trading Halted

Key Benefits

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Acura Pharmaceuticals Inc
  • Avancen MOD Corporation
  • Cara Therapeutics Inc
  • CareFusion Corp
  • Cephalon Inc
  • Curlin Medical, Inc.
  • MORE
Section 1 - About the Company
  • AcelRx Pharmaceuticals Inc - Key Facts
  • AcelRx Pharmaceuticals Inc - Key Employees
  • AcelRx Pharmaceuticals Inc - Key Employee Biographies
  • AcelRx Pharmaceuticals Inc - Major Products and Services
  • AcelRx Pharmaceuticals Inc - History
  • AcelRx Pharmaceuticals Inc - Company Statement
  • AcelRx Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • AcelRx Pharmaceuticals Inc - Business Description
  • AcelRx Pharmaceuticals Inc - Corporate Strategy
  • AcelRx Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • AcelRx Pharmaceuticals Inc - Strengths
  • AcelRx Pharmaceuticals Inc - Weaknesses
  • AcelRx Pharmaceuticals Inc - Opportunities
  • AcelRx Pharmaceuticals Inc - Threats
  • AcelRx Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • AcelRx Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Aug 05, 2019: AcelRx Pharmaceuticals reports second quarter 2019 financial results
  • May 08, 2019: AcelRx Pharmaceuticals reports first quarter 2019 financial results
  • Mar 07, 2019: AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
  • Nov 02, 2018: Acelrx Pharmaceuticals reports third quarter 2018 financial results and provides corporate update
  • Oct 12, 2018: AcelRx Pharmaceuticals Stock Trading Halted
  • Aug 02, 2018: AcelRx Pharmaceuticals reports second quarter 2018 financial results
  • Jul 11, 2018: AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock
  • May 09, 2018: AcelRx Pharmaceuticals Reports First Quarter 2018 Financial Results
  • Mar 27, 2018: AcelRx Pharmaceuticals Names John Saia As General Counsel
  • Mar 08, 2018: AcelRx Pharmaceuticals Reports Fourth Quarter 2017 Financial Results
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • AcelRx Pharmaceuticals Inc, Key Facts
  • AcelRx Pharmaceuticals Inc, Key Employees
  • AcelRx Pharmaceuticals Inc, Key Employee Biographies
  • AcelRx Pharmaceuticals Inc, Major Products and Services
  • AcelRx Pharmaceuticals Inc, History
  • AcelRx Pharmaceuticals Inc, Subsidiaries
  • AcelRx Pharmaceuticals Inc, Key Competitors
  • AcelRx Pharmaceuticals Inc, Ratios based on current share price
  • AcelRx Pharmaceuticals Inc, Annual Ratios
  • AcelRx Pharmaceuticals Inc, Interim Ratios
  • AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • AcelRx Pharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • AcelRx Pharmaceuticals Inc, Performance Chart (2014 - 2018)
  • AcelRx Pharmaceuticals Inc, Ratio Charts
  • AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Zyla Life Sciences
  • Trevena Inc
  • Purdue Pharma LP
  • Hospira Inc
  • Egalet US Inc
  • Curlin Medical, Inc.
  • Collegium Pharmaceutical Inc
  • Cephalon Inc
  • CareFusion Corp
  • Cara Therapeutics Inc
  • Avancen MOD Corporation
  • Acura Pharmaceuticals Inc
Note: Product cover images may vary from those shown
Adroll
adroll